Weeks before many people had even heard of the novel coronavirus, Roland Zahn, Ph.D., was already studying the disease—specifically, how it could be stopped.
In Episode 1 of The Road to A Vaccine series, Lisa Ling interviews scientists and healthcare workers about how vaccines work, the impact of the novel coronavirus and what’s being done globally to create a COVID-19 vaccine.
Alexion’s vision is to continuously raise the bar to deliver on patient expectations with solutions designed for them as people – meaning we want to take the time to understand their social and emotional lives, as well as their medical condition.
As the number of confirmed COVID-19 cases increased in Asia and began to spread to other regions around the world, a team of employees at Gilead’s manufacturing site in La Verne, California met in the early morning of Monday, Feb. 3.
As we work together to navigate the rapidly evolving environment due to COVID-19, our priority continues to be protecting the health of our employees and that of the communities in which we live and work.
For more than 170 years, American Express has been committed to backing our colleagues, our customers, our partners and the communities we serve around the world.
Our newly established testing laboratory in Berlin which supports the fight against the Corona virus is already running: In the lab, our employees – more than 140 have volunteered – are able to conduct up to 1,000 additional SARS-CoV-2 tests per day.
When the news of the coronavirus first emerged, Gilead immediately began to investigate the potential of remdesivir, a medicine we had been studying for many years as part of our extensive research in antivirals.
Empower by GoDaddy is GoDaddy’s global community and philanthropic program equipping entrepreneurs in underserved communities with training, tools and...
Cascale shares insights regarding policy and regulation impacting the consumer goods industry, and highlights how it's supporting members prepare for...
